Peer Review reports
From: Use of rituximab as an induction therapy in anti-glomerular basement-membrane disease
| Original Submission | ||
|---|---|---|
| 23 Sep 2017 | Submitted | Original manuscript |
| 23 Oct 2017 | Author responded | Author comments - Giovanna Clavarino |
| Resubmission - Version 2 | ||
| 23 Oct 2017 | Submitted | Manuscript version 2 |
| 1 Apr 2018 | Reviewed | Reviewer Report - Wilfor Aguirre Quispe |
| 4 Apr 2018 | Reviewed | Reviewer Report - Jesper Bech |
| 21 Apr 2018 | Reviewed | Reviewer Report - Sirirat Anutrakulchai |
| 17 May 2018 | Author responded | Author comments - Giovanna Clavarino |
| Resubmission - Version 3 | ||
| 17 May 2018 | Submitted | Manuscript version 3 |
| 25 Jul 2018 | Reviewed | Reviewer Report - Jesper Bech |
| 29 Jul 2018 | Reviewed | Reviewer Report - Sirirat Anutrakulchai |
| 1 Aug 2018 | Author responded | Author comments - Morgane Heitz |
| Resubmission - Version 4 | ||
| 1 Aug 2018 | Submitted | Manuscript version 4 |
| 6 Sep 2018 | Author responded | Author comments - Morgane Heitz |
| Resubmission - Version 5 | ||
| 6 Sep 2018 | Submitted | Manuscript version 5 |
| 7 Sep 2018 | Author responded | Author comments - Morgane Heitz |
| Resubmission - Version 6 | ||
| 7 Sep 2018 | Submitted | Manuscript version 6 |
| Publishing | ||
| 10 Sep 2018 | Editorially accepted | |
| 20 Sep 2018 | Article published | 10.1186/s12882-018-1038-7 |
You can find further information about peer review here.